Steve Chaussy - Aug 22, 2022 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role: Chief Financial Officer
Signature: /s/ Kenneth L. Londoner, attorney-in-fact
Stock symbol: BSGM
Transactions as of: Aug 22, 2022
Transactions value $: $9,016
Form type: 4
Date filed: 8/24/2022, 10:17 AM
Previous filing: Apr 8, 2022
Next filing: Sep 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSGM	Common Stock	Purchase	$9.02K	+8K	+0.78%	$1.13	1.04M	Aug 22, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person reported a prior award of 200,000 shares of restricted stock units in Table II on a Form 4 filed with the SEC on April 8, 2022. The total reported in Column 5 includes the 200,000 restricted stock units previously reported in Table II and 840,128 shares of common stock. On November 21, 2018 the reporting person filed a Form 4 reporting ownership of 467,330 shares of common stock instead of 466,330 shares of common stock after a purchase of 1,000 shares, due to an inadvertent miscalculation following a 1-for-2.5 reverse stock split. As of August 24, 2022, the reporting person owns 1,040,128 shares of common stock.

Content

The reporting person reported a prior award of 200,000 shares of restricted stock units in Table II on a Form 4 filed with the SEC on April 8, 2022. The total reported in Column 5 includes the 200,000 restricted stock units previously reported in Table II and 840,128 shares of common stock. On November 21, 2018 the reporting person filed a Form 4 reporting ownership of 467,330 shares of common stock instead of 466,330 shares of common stock after a purchase of 1,000 shares, due to an inadvertent miscalculation following a 1-for-2.5 reverse stock split. As of August 24, 2022, the reporting person owns 1,040,128 shares of common stock.